ND-09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR-ABL signaling (vol 46, 136, 2021)

被引：0
|
作者：
Liu, Yan-Hong
Zhu, Man
Lei, Pan-Pan
Pan, Xiao-Yan
Ma, Wei-Na
机构：
来源：
ONCOLOGY REPORTS | 2023年 / 49卷 / 05期
关键词：
D O I：
10.3892/or.2023.8518
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Expression of RKIP in chronic myelogenous leukemia K562 cell and inhibits cell proliferation by regulating the ERK/MAPK pathway
    Li, Bin
    Sun, Baolan
    Zhu, Jianwei
    Zhou, Nina
    Yang, Zhiping
    Gu, Jianhui
    TUMOR BIOLOGY, 2014, 35 (10) : 10057 - 10066
  • [22] Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells
    Zhou, Hui-Jun
    Wang, Wei-Qin
    Wu, Guo-Dong
    Lee, Jun
    Li, Ao
    VASCULAR PHARMACOLOGY, 2007, 47 (2-3) : 131 - 138
  • [23] Consequences of BCR-ABL expression within the hematopietic stem cell in chronic myeloid leukemia (vol 18, pg 399, 2000)
    Kabarowski, JHS
    Witte, ON
    STEM CELLS, 2001, 19 (01) : U7 - U7
  • [24] Contribution of BCR-ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells
    Nambu, Takeru
    Araki, Norie
    Nakagawa, Aiko
    Kuniyasu, Akihiko
    Kawaguchi, Tatsuya
    Hamada, Akinobu
    Saito, Hideyuki
    CANCER SCIENCE, 2010, 101 (01): : 137 - 142
  • [25] IMMUNOLOGICALLY DETECTION OF BCR/ABL FUSION PROTEIN WITH FLOW CYTOMETRY IN K562 CHRONIC MYELOID LEUKEMIA CELLS AND COMPARISON WITH RT-PCR RESULTS
    Kozanoglu, I.
    Aygun, B.
    Boga, I.
    Cansun, C.
    Ustundag, N.
    Baran, Y.
    Maytalman, E.
    Sariturk, C.
    Boga, C.
    Ozdogu, H.
    HAEMATOLOGICA, 2013, 98 : 568 - 568
  • [26] p19INK4d inhibits proliferation and enhances imatinib efficacy through BCR-ABL signaling pathway in chronic myeloid leukemia
    Kuang, Yijin
    Han, Xu
    Cao, Pengfei
    Xiong, Dehui
    Peng, Yuanliang
    Liu, Zhaoping
    Xu, Zhenru
    Liang, Long
    Roy, Mridul
    Liu, Jing
    Nie, Ling
    Zhang, Ji
    BLOOD CELLS MOLECULES AND DISEASES, 2020, 85
  • [27] GENE-TARGETED SPECIFIC-INHIBITION OF CHRONIC MYELOID-LEUKEMIA CELL-GROWTH BY BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES
    SKORSKI, T
    SZCZYLIK, C
    MALAGUARNERA, L
    CALABRETTA, B
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 1991, 29 (03): : 85 - &
  • [28] Betulinic acid induces apoptosis in human chronic myelogenous leukemia (CML) cell line K-562 without altering the levels of Bcr-Abl
    Gopal, DVR
    Narkar, AA
    Badrinath, Y
    Mishra, KP
    Joshi, DS
    TOXICOLOGY LETTERS, 2005, 155 (03) : 343 - 351
  • [29] Acetylshikonin induces apoptosis of human leukemia cell line K562 by inducing S phase cell cycle arrest, modulating ROS accumulation, depleting Bcr-Abl and blocking NF-κB signaling
    Hao, Gangping
    Zhai, Jing
    Jiang, Hanming
    Zhang, Yuanying
    Wu, Mengdi
    Qiu, Yuyu
    Fan, Cundong
    Yu, Lijuan
    Bai, Suyun
    Sun, Lingyun
    Yang, Zhongfa
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 122
  • [30] Cell-penetrating fusion peptides OD1 and OD2 interact with Bcr-Abl and influence the growth and apoptosis of K562 cells
    Wang, Hai-xia
    Xiao, Heng
    Zhong, Liang
    Tao, Kun
    Li, Ya-juan
    Huang, Shi-feng
    Wen, Jian-ping
    Feng, Wen-li
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 385 (1-2) : 311 - 318
12345